Concepedia

Effect of patients' being prone during FDG PET for the diagnosis of breast cancer.

Kenji Yutani, Mitsuaki Tatsumi, Toshiisa Uehara, T Nishimura

American Journal of Roentgenology · 1999 · 41 citations · 4 references

Concepts

Breast OncologyCancer RiskMedicinePet-mriDiagnosisM TatsumiBreast ImagingBreast CancerBreast Cancer.k YutaniOncologyRadiation OncologyFdg PetNuclear MedicineCancer ResearchRadiologyHealth Sciences

Abstract

Effect of patients' being prone during FDG PET for the diagnosis of breast cancer.K Yutani, M Tatsumi, T Uehara and T NishimuraAudio Available | Share

References

4

The applications of PET in clinical oncology.

Ludwig G. Strauss, Peter S. Conti · PubMed · 1991 · 855 citations

Engineering, Oncologic Imaging, Pet-mri +16

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.

Lee P. Adler, Joseph P. Crowe, Nadia Al‐Kaisi et al. · Radiology · 1993 · 374 citations

Positron Emission Tomography, Breast Oncology, Breast Masses +15

Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.

R Taillefer, A. Robidoux, R Lambert et al. · PubMed · 1995 · 202 citations

Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.

Javier Villanueva‐Meyer, Morton H. Leonard, E. G. Briscoe et al. · PubMed · 1996 · 104 citations